Matthew J. Carpenter Ph.D.
Dr. Carpenter received his Ph.D. in Clinical Psychology from the University of Vermont in 2002, and relocated to Charleston for internship and postdoctoral training. He joined the MUSC faculty in 2006 and is currently a Professor, jointly affiliated with the Addiction Sciences Division within the Department of Psychiatry, and also the Hollings Cancer Center, Cancer Control Program, where he co-directs the Tobacco Research Program. His primary research interests relate to tobacco use across a broad methodological continuum: from lab-based studies of craving and nicotine dependence, to small and large scale clinical trials for smoking cessation, to public health policy for effective tobacco control. He is principally funded through NIH, and is the prior/current recipient of a Career Development Award (K23) and several R01s and R21s (NCI & NIDA), and foundation grants, all as Principal Investigator. Dr. Carpenter is currently co-PI of the NIDA Clinical Trials Network, Southern Consortium. He has served on a number of NIH study sections, and is currently the Chair of Addiction Risks and Mechanisms (ARM). He serves on the editorial board of both CNS Drugs and the Journal of Behavioral Medicine. Dr. Carpenter has mentored a number of junior investigators across various grant mechanisms (T32, F32, K01, K23). Honored with several state and federal awards, Dr. Carpenter was most recently awarded with the South Carolina Governor’s Award for Research Excellence (2015).